The importance of HER-2 receptor in some cancers such as breast and gastric cancers has been verified in a lot of recent studies, whereas there are few reports focused on HER-3 as a significant factor involved in carcinogenesis 12. This evidence concerns the gene ERBB3 and gastric cancer.